Alembic Pharma receives USFDA approval for doxycycline
Alembic Pharmaceuticals has received the final USFDA approval for Abbreviated New Drug Application (ANDA) of anti-bacterial Doxycycline capsules USP 75 mg and 100 mg. The […]
USFDA
Strides Shasun receives USFDA approval for memantine hydrochloride tablets
Strides Shasun today has received final USFDA approval for memantine hydrochloride tablets used in the treatment of dementia. The product will be manufactured at the […]
Cadila receives USFDA approval to market cyproheptadine hydrochloride
Zydus Cadila has received final USFDA approval to market antihistamine Cyproheptadine Hydrochloride tablets in the US market. The tablets are used to relieve allergy symptoms […]
Cadila receives USFDA approval to market levofloxacin injection in USA
Zydus Cadila has received final USFDA approval to market levofloxacin injection, used to treat bacterial infections, in the American market. The drug injection is made […]
Glenmark Pharma receives USFDA approval for Atomoextine capsules
Glenmark Pharmaceuticals has received final USFDA approval for generic version of Strattera capsules, used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The company has been […]
Cadila receives USFDA approval for Felbamate
Zydus Cadila has received final USFDA approval to market Felbamate tablets, used to treat seizures in people with epilepsy, in the American market. The company […]
Cadila receives USFDA approval to market Mirtazapine in USA
Zydus Cadila has received USFDA approval to market Mirtazapine orally disintegrating tablets, an anti depressant, in the US market. The drug will be marketed in […]
Zydus Cadila to market mesalamine tablet in USA
Zydus Cadila has received approval from USFDA to market mesalamine tablets used for the treatment of ulcerative colitis. The US FDA has given its final […]
Zydus Cadila receives USFDA approval for Doxazosin tablets
Zydus Cadila has received final USFDA approval to market Doxazosin tablets, used for treatment of high blood pressure and urinary retention associated with enlargement of […]
Jubilant Life Sciences receives USFDA approval for Bupropion Hydrochloride
Jubilant Life Sciences through its subsidiary has received final USFDA approval for Bupropion Hydrochloride extended-release tablets, used for the treatment of major depressive disorder and […]